|
[Related PubMed/MEDLINE]
Total Number of Papers: 50
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: AA |
| Long Form |
: acetaminophen |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2017 |
Investigation of Oral Preparation That Is Expected to Improve Medication Administration: Preparation and Evaluation of Oral Gelling Tablet Using Sodium Alginate. |
AG |
| 2 |
2016 |
Preparation of an oral acetaminophen film that is expected to improve medication administration: Effect of polyvinylpyrrolidone on physical properties of the film. |
CMC, PVP |
| 3 |
2013 |
Change in the gene expression of the N-methyl-D-aspartate receptor 2C subunit by dietary beta-naphthoflavone, indole-3-carbinol, or acetaminophen in the rat liver. |
BNF, I3C |
| 4 |
2013 |
Photodegradation of pharmaceuticals in the aquatic environment by sunlight and UV-A, -B and -C irradiation. |
AM, DP, DX, HPLC, IM, NP, PH, RL, SL, UV |
| 5 |
2012 |
Examination of factors that delay the elution of acetaminophen from over-the-counter drugs. |
CP, ET, OTC |
| 6 |
2011 |
Effects of kale ingestion on pharmacokinetics of acetaminophen in rats. |
AA-G, AUC |
| 7 |
2011 |
Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1. |
CM, COX, EP, HO-1, LOX, ROS |
| 8 |
2009 |
Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice. |
AA-GLUC, AA-SULF, MRPs, NAPQI, NQO1, Nrf2 |
| 9 |
2009 |
Preparation and evaluation of medicinal carbon tablets with different saccharides as binders. |
MAN, MC, MT, SOR, XYL |
| 10 |
2009 |
Studies on preventive effects of diphenyl diselenide on acetaminophen-induced hepatotoxicity in rats. |
ALP, AST, delta-ALA-D, gamma-GT, GST, LDH, PhSe |
| 11 |
2007 |
Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. |
TSA |
| 12 |
2006 |
Melatonin protects on toxicity by acetaminophen but not on pharmacological effects in mice. |
MLT, ROS |
| 13 |
2006 |
Protective effects of resveratrol against acetaminophen-induced toxicity in mice. |
CL, MDA, MPO, RVT, TNF-alpha |
| 14 |
2004 |
Assessment of the protective potential of Premna tomentosa (L. Verbenaceae) extract on lipid profile and lipid-metabolizing enzymes in acetaminophen-intoxicated rats. |
PT |
| 15 |
2003 |
Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method. |
FT method, GI, PPA, TP |
| 16 |
2003 |
Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. |
AST, BUN, MDA, MPO, NAC |
| 17 |
2000 |
Effects of benzothiazole on the xenobiotic metabolizing enzymes and metabolism of acetaminophen. |
BT, GST, P450s, UDPGT |
| 18 |
2000 |
Effects of molybdate and pentachlorophenol on the sulfation of acetaminophen. |
PAPS, PCP |
| 19 |
2000 |
Effects of phenethylisothiocyanate on the expression of glutathione S-transferases and hepatotoxicity induced by acetaminophen. |
GST |
| 20 |
2000 |
Potentiation of acetaminophen hepatotoxicity by doxapram in mouse primary cultured hepatocytes. |
DOP |
| 21 |
2000 |
Yang-Gan-Wan protects mice against experimental liver damage. |
AlOH, ALT, SDH |
| 22 |
1999 |
Alteration of acetaminophen metabolism by sulfate and steroids in primary monolayer hepatocyte cultures of rats and mice. |
DEX, PCN, ST |
| 23 |
1998 |
Potentiation of acetaminophen hepatotoxicity and mortality by doxapram in mice. |
DOP |
| 24 |
1997 |
Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats. |
AA-G, AA-S, CIS, HCBD |
| 25 |
1995 |
Acetaminophen does not decrease hepatic 3'-phosphoadenosine 5'-phosphosulfate in mice. |
PAPS |
| 26 |
1995 |
Effects of acetaminophen on the ultrastructure of isolated rat hepatocytes. |
ER, IHC, NAPQI |
| 27 |
1994 |
Effects of N-acetylcysteine and dithiothreitol on glutathione and protein thiol replenishment during acetaminophen-induced toxicity in isolated mouse hepatocytes. |
--- |
| 28 |
1994 |
Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. |
NAC, RCR |
| 29 |
1993 |
Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. |
OA |
| 30 |
1993 |
Simultaneous measurements of glutathione and activated sulphate (PAPS) synthesis rates and the effects of selective inhibition of glutathione conjugation or sulphation of acetaminophen. |
BSO, DCNP |
| 31 |
1993 |
Synthesis rates of glutathione and activated sulphate (PAPS) and response to cysteine and acetaminophen administration in glutathione-depleted rat hepatocytes. |
DEM |
| 32 |
1992 |
Effect of pregnenolone-16 alpha-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. |
DEX, PCN |
| 33 |
1992 |
Effects of 3-methylcholanthrene or diethyl maleate on the hepatotoxicity of acetaminophen. |
3MCh, DEM |
| 34 |
1992 |
Effects of cysteine and acetaminophen on the syntheses of glutathione and adenosine 3'-phosphate 5'-phosphosulfate in isolated rat hepatocytes. |
PAPS |
| 35 |
1992 |
Effects of microsomal enzyme inducers upon UDP-glucuronic acid concentration and UDP-glucuronosyltransferase activity in the rat intestine and liver. |
3-MC, BaP, BHA, HA, NA, PB, PCN, TCDD, TSO, UDPG, UDPGA, UDPGT |
| 36 |
1992 |
Homeostasis of sulfate and 3'-phosphoadenosine 5'-phosphosulfate in rats after acetaminophen administration. |
PAPS |
| 37 |
1992 |
Protective effects of fulvotomentosides on acetaminophen-induced hepatotoxicity. |
Ful |
| 38 |
1991 |
Protective effect of pregnenolone-16 alpha-carbonitrile on acetaminophen-induced hepatotoxicity in hamsters. |
PCN, SDH |
| 39 |
1991 |
Protective effect of zinc in the hepatotoxicity of bromobenzene and acetaminophen. |
BB, MDA, MT |
| 40 |
1990 |
Dose-dependent intestinal glucuronidation and sulfation of acetaminophen in the rat in situ. |
AA-glucuronide, AA-sulfate |
| 41 |
1990 |
Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction. |
PB, TSO |
| 42 |
1989 |
Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemicals that alter acetaminophen hepatotoxicity. |
--- |
| 43 |
1989 |
Dynamics of glutathione levels in liver and indicatory enzymes in serum in acetaminophen intoxication in mice. |
SDH, SGPT |
| 44 |
1988 |
Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals. |
Gal, UDPGA |
| 45 |
1988 |
Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. |
--- |
| 46 |
1986 |
Comparison of the effects of sodium sulfate and N-acetylcysteine on the hepatotoxicity of acetaminophen in mice. |
NAC |
| 47 |
1986 |
Hepatic UDP-glucuronic acid regulation during acetaminophen biotransformation in rats. |
--- |
| 48 |
1985 |
Biliary excretion of acetaminophen in diabetic and hyperthyroid rats. |
--- |
| 49 |
1985 |
Effects of phenobarbital, phorone and carbon tetrachloride pretreatment on the biliary excretion of acetaminophen in rats. |
--- |
| 50 |
1984 |
Biliary excretion of acetaminophen in ureter-ligated rats. |
--- |
|
A Search Service for Abbreviation / Long Form
